Immunotherapy for Prostate Cancer: Lessons from Responses to Tumor-Associated Antigens

Prostate cancer (PCa) is the most common cancer in men and the second most common cause of cancer-related death in men. In recent years, novel therapeutic options for PCa have been developed and studied extensively in clinical trials. Sipuleucel-T is the first cell-based immunotherapeutic vaccine fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Westdorp, Harm, Sköld, Annette E., Snijer, Berit A., Franik, Sebastian, Mulder, Sasja F., Major, Pierre P., Foley, Ronan, Gerritsen, Winald R., de Vries, I. Jolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018526/
https://www.ncbi.nlm.nih.gov/pubmed/24834066
http://dx.doi.org/10.3389/fimmu.2014.00191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018526/
https://www.ncbi.nlm.nih.gov/pubmed/24834066
http://dx.doi.org/10.3389/fimmu.2014.00191

Ejemplares similares